🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT05430971
Recruiting Observational

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971 · tracked via the Priya Life Science India tracker
Sponsor
Immune Oncology Research Institute
Phase
Observational
Started
2022-07-01
Last updated
2026-06-05

Condition(s) studied

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Study summary

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare hematologic malignancy. Despite recent advances, at present there is no consensus on the optimal treatment of BPDCN. The optimal therapy of disease remains to be determined, and due to the rarity of cases, there is a need for international collaboration to collect data on BPDCN clinical presentations, diagnostics, treatment regimens and outcomes. Therefore, the objectives of this study are: (1) to build a large database of patients with BPDCN, (2) to investigate the characteristics and outcome of the disease with different treatment regimens, (3) to evaluate prognostic factors, and (4) to generate data-based prospective treatment recommendations.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of BPDCN * Signed informed consent form for prospective patients Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (22)

FacilityCityRegionStatus
Sylvester Comprehensive Cancer Center, University of Miami Miami Florida Recruiting
Moffitt Cancer Center Tampa Florida Recruiting
Seattle Children's Cancer and Blood Disorders Center Seattle Washington Recruiting
Hematology Center named after prof. R. Yeolyan Yerevan Armenia Recruiting
University of Calgary Calgary Alberta Recruiting
Children's Hospital of Eastern Ontario, University of Ottawa Ottawa Ontario Recruiting
Cyprus Society of Haematology Nicosia Cyprus Recruiting
Oncology Center, Mansoura University Faculty of Medicine Al Mansurah Egypt Recruiting
M. Iashvili Children's Central Hospital Tbilisi Georgia Recruiting
Department of Medical Oncology, Dr. B.R.A Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi India Recruiting
Pediatric Hematology Oncology, Children's Welfare Teaching Hospital, Medical City, College of Medicine, University of Baghdad Baghdad Iraq Recruiting
University of Perugia - Azienda Ospedaliera Perugia Perugia Italy Recruiting
Department of Biomedicine and Prevention, University of Rome Tor Vergata Roma Italy Recruiting
King Hussein Cancer Center (KHCC) Amman Jordan Recruiting
Department of hematology, Kuwait Cancer Control Center Kuwait City Kuwait Recruiting
Fundeni Clinical Institute, Department of Acute Leukemia Bucharest Romania Recruiting
China Medical University Children's Hospital Taichung Taiwan Recruiting
Turkish Pediatric Cancer Registry Ankara Turkey (Türkiye) Recruiting
Istanbul University, Oncology Institute Istanbul Turkey (Türkiye) Recruiting
University of Health Sciences, Umraniye Research and Education Hospital, Pediatric Hematology and Oncology Department, Pediatric Bone Marrow Transplantation Unit Istanbul Turkey (Türkiye) Recruiting
Broomfield Hospital, Haematology Mid and South Essex University Hospitals Group Chelmsford Essex Recruiting
United Lincolnshire Teaching Hospital NHS Trust Lincoln Lincolnshire Recruiting

More Immune Oncology Research Institute trials in India

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05430971 on ClinicalTrials.gov ↗ ← All trials in India